Document is current
Any future updates will be listed below
-
Authors
Kazibwe, Richard
Rikhi, Rishi
Mirzai, Saeid
Ashburn, Nicklaus P.
Schaich, Christopher L.
Shapiro, Michael
-
Funding
Funding for this research was provided by:
Wake Forest University
- License Information
-
More Information
Article History
Accepted: 29 September 2024
First Online: 9 November 2024
Declarations
:
: The review process for this article has adhered to the ethical guidelines and standards set forth by the relevant academic and professional bodies. The authors have complied with all requirements for ethical review, and where necessary, have obtained approval from institutional review boards or ethics committees.
: This article does not contain any studies with human or animal subjects performed by any of the authors. No animal or human subjects by the authors were used in this study.
: Michael D. Shapiro is supported by institutional grants from Amgen, Arrowhead, Boehringer Ingelheim, 89Bio, Esperion, Novartis, Ionis, Merck, New Amsterdam, and Cleerly. He has participated in Scientific Advisory Boards with Amgen, Agepha, Ionis, Novartis, New Amsterdam, and Merck. He has served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Shanghai Pharma Biotherapeutics, Kaneka, Novo Nordisk, Arrowhead, and Tourmaline. Nicklaus P. Ashburn receives funding from NHLBI (K23HL169929), AHRQ (R01HS029017), and the Emergency Medicine Foundation. Saeid Mirzai is supported by the NHLBI (T32HL076132).Dr Richard Kazibwe declares no conflict of interest.Dr C. Schaich declares no conflict of interest.
